Clinical Trials Browser

Phase 2 × Unknown × Leukemia, Large Granular Lymphocytic × Clear all

NCT05941156 2023-07-12

Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Large Granular Lymphocytic, Lymphoma, Extranodal NK-T-Cell